Khronicheskiy pankreatit: kak dolgo lechit' i chego pri etom ozhidat'?


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Chronic pancreatitis (CP) is a disease with significant heterogeneity of pathological process and clinical manifestations. Data with class (level) of evidence I for diagnostic and therapeutic treatments are not available. Despite the lack of scientific validity, there are different national standards for the conservative treatment of CP in the world; they form the foundation for this review, with an emphasis on domestic health care and taking into account the opportunities and challenges for medical practitioners in Russia today.

Full Text

Restricted Access

About the authors

Yu. A Kucheryavyy

Email: proped@mail.ru

References

  1. Frulloni L, Falconi M, Gabbrielli, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2 010;42(6):381-406.
  2. Bornman PC, Botha JF, Ramos JM, et al. Guideline for the diagnosis and treatment of chronic pancreatitis. S Afr Med J 2010;100(12 Pt 2):845-60.
  3. Guidelines for the diagnosis and treatment of chronic pancreatitis (Nanjing, 2005). Chin J Dig Dis 2005;6:198-201.
  4. Warshaw AL, Banks PA, Fernandez-Del Castillo C AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998;115:765-76.
  5. Tandon RK, Sato N, Garg PK. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol 2002;17:508-18.
  6. Schneider A, Luhr JM, Singer MV. The M-ANNHEIM Classification of Chronic Pancreatitis: Introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterology 2007;42:101-19.
  7. Talamini G, Bassi C, Falconi M, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci 1999;44:1301-11.
  8. Lin Y, Tamakoshi A, Hayakawa T, et al. Cigarette smoking as a risk factor for chronic pancreatitis: a case-control study in Japan. Research Committee on Intractable Pancreatic Diseases. Pancreas 2000;21:109-14.
  9. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-45.
  10. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:687-88.
  11. Pfutzer RH, Barmada MM, Brunskil APJ, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119:615-23.
  12. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. New Engl J Med 2006;335:2670-76.
  13. Akari T, Ueda M, Ogawa K, Tsuji T. Histological pancreatitis in end-stage renal disease. Int J Pancreatology 1992; 12:263-69.
  14. Mergener K, Baillie J. Chronic pancreatitis. Lancet 1997;340:1379-85.
  15. Gullo L, Barbara L, Labo G. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology 1988;95:1063-68.
  16. Witt H, Apte MV, Keim V, et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007;132:155 7-73.
  17. Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinico-morphological long-term study. Gastroenterology 1996;111:224-31.
  18. Ammann RW, Muellhaupt B. Progression of alcoholic acute to chronic pancreatitis. Gut 1994;35:552-56.
  19. Cahen DL, Gouma DJ, Nio Y, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med 2007; 356:676-84.
  20. Hayakawa T, Kondo T, Shibata T, et al. Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis. Dig Dis Sci 1989;34:33-8.
  21. Mullhaupt B, Truninger K, Ammann R. Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study. Z Gastroenterol 2005;43:1293-301.
  22. Thuluvath PJ, Imperio D, Nair S, et al. Chronic pancreatitis. Long-term pain relief with or without surgery, cancer risk, and mortality. J Clin Gastroenterol 2003;36:159-65.
  23. Bourliere M, Barthet M, Berthezene P, et al. is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut 1991 ;32:1392-95.
  24. Lowenfels AB, Zwemer FL, Jhangiani S, et al. Pancreatitis in a native American Indian population. Pancreas 1987;2:694-97.
  25. Morton C, Klatsky AL, Udaltsova N. Smoking, coffee, and pancreatitis. Am J Gastroenterol 2004;99:731-38.
  26. Nakamura Y, Kobayashi Y, ishikawa A, et al. Severe chronic pancreatitis and severe liver cirrhosis have different frequencies and are independent risk factors in male Japanese alcoholics. J Gastroenterol 2004;39:879-87.
  27. Rothenbacher D, Low M, Hardt PD, et al. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol 2005;40:697-704.
  28. Talamini G, Vaona B, Bassi C, et al. Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-associated pancreatitis. J Clin Gastroenterol 2000;31:314-17.
  29. Yen S, Hsieh CC, MacMahon B. Consumption of alcohol and tobacco and other risk factors for pancreatitis. Am J Epidemiol 1982; 116:407-14.
  30. Talamini G, Bassi C, Falconi M, et al. Cigarette smoking: an independent risk factor in alcoholic pancreatitis. Pancreas 1996;12:131-37.
  31. imoto M, DiMagno EP. Cigarette smoking increases the risk of pancreatic calcification in late-onset but not early-onset idiopathic chronic pancreatitis. Pancreas 2000;21:115-19.
  32. Maisonneuve P, Lowenfels AB, Mullhaupt B, et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut 2005;54:510-14.
  33. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in patients with acute and chronic pancreatitis. Gastroenterol Clin North Am 1999;28:695-707.
  34. Dutta SK, Bustin MP, Russell RM, et al. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann intern Med 1982; 97:549-52.
  35. Forsmark CE. Chronic pancreatitis and malabsorption. Am J Gastroenterol 2004;99:1355-57.
  36. Moran CE, Sosa EG, Martinez SM, et al. Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 1997;92:867-71.
  37. Haaber AB, Rosenfalck AM, Hansen B, et al. Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. int J Pancreatol 2000;27:21-7.
  38. Ahmad SA, Wray C, Rilo HL, et al. Chronic pancreatitis: recent advances and ongoing challenges. Curr Probl Surg 2006;43:12 7-38.
  39. Winstead NS, Wilcox CM. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis - A review. Pancreatology 2009;9:344-50.
  40. Brown A, Hughes M, Tenner S, et al. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am J Gastroenterol 1997;92:2032-35.
  41. Heijerman HG, Lamers CB, Bakker W. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann intern Med 1991 ;114:200.
  42. Vecht J, Symersky T, Lamers CB, Masclee AA. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. J Clin Gastroenterol 2006;40(8):721 -25.
  43. Nakamura T, Arai Y, Tando Y, et al. Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis. Clin Ther 1995;17(3):448-59.
  44. Lieb JG, Forsmark CE. Review article: pain and chronic pancreatitis. Aliment Pharmacol Ther 2009;29:706-19.
  45. Tringali A, Boskoski i, Costamagna G. The role of endoscopy in the therapy of chronic pancreatitis. Best Pract Res Clin Gastroenterol 2008; 22:145-65.
  46. Niemann T, Madsen LG, Larsen S, et al. Opioid treatment of painful chronic pancreatitis. int J Pancreatol 2000;27:235-40.
  47. Bloechle C, izbicki JR, Knoefel WT, et al. Quality of life in chronic pancreatitis - results after duodenum-preserving resection of the head of the pancreas. Pancreas 1995;11:77-85.
  48. Wilder-Smith CH, Hill L, Osler W, et al. Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci 1999;44:1107-16.
  49. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009; 136:149-59.
  50. Dominguez-Munoz JE, iglesias-Garcia J, Vilarino-insua M, et al. 13Cmixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007;5:484-88.
  51. Dumasy V, Delhaye M, Cotton F, et al. Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol 2004;99:1350-54.
  52. Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007;9:116-22.
  53. Waljee AK, Dimagno MJ, Wu BU, et al. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. Aliment Pharmacol Ther 2009;29:235-46.
  54. Krishnamurty DM, Rabiee A, Jagannath SB, et al. Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis. Ther Clin Risk Management 2009;5:507-20.
  55. Kuhnelt P, Mundlos S, Adler G. Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity. Z Gastroenterol 1991 ;29:417-21.
  56. Layer P, Keller J, Lankisch PG. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001;3:101-08.
  57. Dominguez-Munoz JE, iglesias-Garcia J, iglesias-Rey M, et al. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut 2006;55:1056-57.
  58. Trespi E, Ferrieri A. intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin 1999;15(1):47-52.
  59. Czako L, Takacs T, Hegyi P, et al. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003;17:597-603.
  60. Kuhn RJ, Gelrud A, Munck A, Caras S. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. Adv Ther 2010;2 7( 12):895-916.
  61. Friess H, Kleeff J, Malfertheiner P, et al. influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers. int J Pancreatol 1998;23(2):115-23.
  62. Malka D, Hammel P, Maire F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002;51:849-52.
  63. international Expert Committee. international Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
  64. Joffe Bi, Jackson WPU, Bank S, et al. Effect of oral hypoglycaemic agents on glucose tolerance in pancreatic diabetes. Gut 1972;13:285-88.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies